Fareon
fareon.co
Actively hiring
Neurotech & Neuromodulation
Neurology & CNS Therapeutics
As featured in
View 1 job
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$10.1M
4 rounds on record
Latest round
$2M
Convertible Note · Aug 2026 · 2 mo ago
Team
11-50
employees, estimated range
Hiring now
1
+1 posted in 30 days
Backers
1
Lionheart Ventures
The money's age
Fresh money
2 months since the last round · and hiring
Momentum
48/100
hiring for its size, in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 11
Raised a round Convertible Note $2M · SEC Form D
Aug 11
Raised a round Convertible Note $7M · SEC Form D
May 9, 2024
Raised a round Convertible Note $100k · SEC Form D
Jan 31, 2023
Raised a round Convertible Note $953k · SEC Form D
2018
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Aug 2026 | $2M | — | SEC Form D |
| Convertible Note | Aug 2026 | $7M | — | SEC Form D |
| Convertible Note | May 2024 | $100k | — | SEC Form D |
| Convertible Note | Jan 2023 | $953k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Fareon, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Blake GurfeinExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Neurocarrus
backs Kernel
backs Dydema
backs NeuroHarmonics
backs NeuroHarmonics
backs NeuroHarmonics
Similar startupsby what they do, their industry and backers
Midstage biotech developing GRX-917, a non-addictive anxiety treatment with minimal side effects. Pivotal trials 2027, projected FDA…
What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug…
Five Discovery is a regenerative neurology biotech developing non-hallucinogenic neuroplastogens to repair brain circuits in Parkinson’s…
Dydema builds AI models for neurotech and brain–computer interfaces, and records the brain data to train them. Y Combinator F26.
Pioneering the Future of Brain Health. Sanmai was created as a public benefit corporation by world-leading experts in neuromodulation and…
For Clinics For Developers Login Contact Us Developing the future of brain health Founded by Bryan Johnson in 2016, Kernel builds…
Overview
Fareon is pioneering a new class of noninvasive biophysics therapy designed to promote repair and recovery in the brain — without drugs or systemic side effects.
News
Fareon Announces Publication in Brain Communications Demonstrating Positive Impacts of Biophysics on Cognition and Mood in Long Covid Patients
SAN FRANCISCO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Fareon, a clinical-stage biophysics company pioneering novel therapies for neurological diseas...
Read more
Report
Fareon Announces Publication In Brain Communications Demonstrating Positive Impacts Of Biophysics On Cognition And Mood In Long Covid Patients
Fareon Announces Publication In Brain Communications Demonstrating Positive Impacts Of Biophysics On Cognition And Mood In Long Covid Patients. Randomized, sham-controlled study demonstrates strong usability ratings for at-home administration, positive im
Read more
Report
Fareon Announces New Paper Linking Biomarkers for Lower Predicted Brain Age, Reduced Inflammation, and Activation of Repair to Its Noninvasive Biophysics Treatment
Plasma proteomics data reveal biological changes in people receiving Fareon Restore at home, supporting the potential to treat brain disorders through magnetic fields
Read more
Report
Fareon Announces New Paper Linking Biomarkers for Lower Predicted Brain Age, Reduced Inflammation, and Activation of Repair to Its Noninvasive Biophysics Treatment
Plasma proteomics data reveal biological changes in people receiving Fareon Restore at home, supporting the potential to treat brain disorders through magnetic fields Restoration of lost brain function may be possible The first data suggesting that restor
Read more
Report
Fareon Announces New Paper Linking Biomarkers for Lower Predicted Brain Age, Reduced Inflammation, and Activation of Repair to Its Noninvasive Biophysics Treatment
Read more
Report
Fareon Announces New Paper Linking Biomarkers for Lower Predicted Brain Age, Reduced Inflammation, and Activation of Repair to Its Noninvasive Biophysics Treatment
Read more
Report
Fareon Announces Oral Presentation of First-in-Class Biophysics Treatment Results in Patients with Cognitive Impairment from Long COVID at the 2026 ISLC-PAIS Annual Meeting
Caption: The Fareon Restore biophysics platform delivers proprietary Microtesla Magnetic Therapy (MMT) in order to activate biological pathways associated with resolution of inflammation and oxidative stress, repair, and recovery in the brain. Randomized,
Read more
Report
Tech stack
Technologies named in job postings at Fareon over the last 12 months, by layer, with the share of postings for each.
Technologies in use
5
Postings analysed
1
Stack modernity
64/100
Practices & domains
Design Controls
Design History File
ISO 13485
FDA 510(k)
IEC 62304
Sign in to see how your skills match this stack
Sign In
People
Blake Gurfein
Executive Officer, Director
Tara Lemmey
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
10/22/2026
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Product
100% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Francisco
San Francisco
United States
HQ
1 open roles 1 posted in 90 days 10-50 est. staff
hires for Product
Jobs
≈ $119k – $236k per year (Estimated) • In office • Full-Time • 3+ years exp • Bachelor's Degree • San Francisco
ISO 13485
IEC 62304
FDA 510(k)
Design Controls
Design History File
Apply